Evidence map›Paper›PMID 35433741›Full record

ArticleFrontiers in medicine2022

Isoliquiritin Ameliorates Cisplatin-Induced Renal Proximal Tubular Cell Injury by Antagonizing Apoptosis, Oxidative Stress and Inflammation.

Zhiyin Pei, Meng Wu, Hanqing Yu, Guangfeng Long, Zhen Gui, Xiaonan Li, Hongbing Chen, Zhanjun Jia, Weiwei Xia

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Protective Effects of Licorice (Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Food & nutrition research · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Frontiers in pharmacology · 2023
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhiyin PeiDepartment of Clinical Laboratory, Children's Hospital of Nanjing Medical University, Nanjing, China.
Meng WuDepartment of Clinical Laboratory, Children's Hospital of Nanjing Medical University, Nanjing, China.
Hanqing YuDepartment of Clinical Laboratory, Children's Hospital of Nanjing Medical University, Nanjing, China.
Guangfeng LongDepartment of Clinical Laboratory, Children's Hospital of Nanjing Medical University, Nanjing, China.
Zhen GuiDepartment of Clinical Laboratory, Children's Hospital of Nanjing Medical University, Nanjing, China.
Xiaonan LiDepartment of Children Health Care, Children's Hospital of Nanjing Medical University, Nanjing, China.
Hongbing ChenDepartment of Clinical Laboratory, Children's Hospital of Nanjing Medical University, Nanjing, China.
Zhanjun JiaDepartment of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China.
Weiwei XiaDepartment of Clinical Laboratory, Children's Hospital of Nanjing Medical University, Nanjing, China.
Second Affiliated Hospital of Nanjing Medical University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is a clinical syndrome characterized by morbidity, mortality, and cost.

Indexed as

apoptosiscisplatininflammationoxidative stressrenal proximal tubular cells

Identifiers

PMID35433741
PMCPMC9005826
OpenAlexW4220765860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.